Evol Science Overview

  • Founded
  • 2014
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Evol Science General Information


Owner and operator of a biotechnology company intended to identify and therapeutically exploit mechanisms of cancer cell resistance. The company's proteomics platform, metadata analysis and predictive analytics develops new targeted therapies to treat various diseases such as pancreatic cancer, acquired resistance metastatic melanoma and others, enabling doctors to make the deadly cancers survivable.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Application Software
Other Pharmaceuticals and Biotechnology
Primary Office
  • 3711 Market Street
  • Suite 800
  • Philadelphia, PA 19104
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Evol Science Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view Evol Science’s complete valuation and funding history, request access »

Evol Science Executive Team (4)

Name Title Board Seat Contact Info
Joseph Driscoll Co-Founder & Chief Executive Officer
Vikram Bhattacharjee Co-Founder & Primary Scientist
Tim Yen Ph.D Interim CSO
Andy Andrews Ph.D Co-Founder
To view Evol Science’s complete executive team members history, request access »

Evol Science Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Science Center Accelerator/Incubator 000 0000 000000 0
To view Evol Science’s complete investors history, request access »